Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B6JV
|
||||
Former ID |
DNC004058
|
||||
Drug Name |
SB-201993
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Psoriasis [ICD9: 696; ICD10:L40] | Discontinued in Phase 2 | [545457] | ||
Structure |
Download2D MOL |
||||
Formula |
C32H37NO6S
|
||||
Canonical SMILES |
COC1=CC=C(C=C1)CCCCCCCCOC2=C(N=C(C=C2)CSCC3=CC=CC(=C3)C<br />(=O)O)C=CC(=O)O
|
||||
InChI |
1S/C32H37NO6S/c1-38-28-15-12-24(13-16-28)9-6-4-2-3-5-7-20-39-30-18-14-27(33-29(30)17-19-31(34)35)23-40-22-25-10-8-11-26(21-25)32(36)37/h8,10-19,21H,2-7,9,20,22-23H2,1H3,(H,34,35)(H,36,37)/b19-17+
|
||||
InChIKey |
QQUXZUFSDIOIFJ-HTXNQAPBSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Leukotriene B4 receptor 1 | Target Info | Inhibitor | [534210] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
NetPath Pathway | IL4 Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.